Monatepil
Tools
Actions
General
Print/export
Print/export
In other projects
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 11:50, 17 October 2014 (Updating {{chembox}} (changes to verified and watched fields - updated 'ChemSpiderID_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'Verifiedfields', 'Watchedfields') per Chem/Drugbox validation (report [[Wikipedia_talk:WikiProje...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 11:50, 17 October 2014 by CheMoBot (talk | contribs) (Updating {{chembox}} (changes to verified and watched fields - updated 'ChemSpiderID_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'Verifiedfields', 'Watchedfields') per Chem/Drugbox validation (report [[Wikipedia_talk:WikiProje...)
Names | |
---|---|
IUPAC name
(RS)-N-(6,11-dihydrobenzo[c][1]benzothiepin-11-yl)-4-[4-(4-fluorophenyl)-1-piperazinyl]butanamide
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider |
|
KEGG |
|
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C28H30FN3OS | |
Molar mass | 475.620703 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Monatepil is a calcium channel blocker and α1-adrenergic receptor antagonist used as an antihypertensive.[1]
Synthesis
References
- ^ Sugimoto T, Hosoki K, Karasawa T (July 1995). "Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil". Journal of Cardiovascular Pharmacology. 26 (1): 55–60. doi:10.1097/00005344-199507000-00009. PMID 7564365.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/jm00107a009, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1021/jm00107a009
instead.
Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
---|---|---|---|---|---|
Other antagonists |
| ||||
|
Calcium |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Potassium |
| ||||||||||||||||||||||||
Sodium |
| ||||||||||||||||||||||||
Chloride |
| ||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||
α1 |
| ||||
---|---|---|---|---|---|
α2 |
| ||||
β |
| ||||
Classes | |
---|---|
Antidepressants (Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |
|
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Monatepil&oldid=629971912"
Hidden categories:
- CS1 maint: multiple names: authors list
- Articles without EBI source
- Articles without UNII source
- Articles with changed ChemSpider identifier
- Articles with changed KEGG identifier
- Articles with changed InChI identifier
- Articles containing unverified chemical infoboxes
- Pages using Chembox with unknown parameters
- Articles with short description
- Short description matches Wikidata
- All stub articles